Avadel Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for LUMRYZ for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.
Advertisement
Researchers have identified a genetic variant that may help predict the development of severe ulcerative colitis.
Dr. Benjamin Dekel shared insights on kidney regenerative medicine with Nephrology Times.
Despite a downward trend, there remains a high rate of first-time prescriptions of benzodiazepines in older adults.
Most of the research performed up to this point on the influence of clonal dynamics in MDS has focused on high-risk disease.
A majority of patients in the study had complete remission of disease within bone marrow with the combination therapy.
Officials plan to submit a supplemental New Drug Application for the use of the combination therapy in this setting.
Researchers examined the effect of kidney transplantation (KT) on cognitive abilities.
A study examined the association between gross hematuria after COVID-19 vaccination and renal prognosis in IgAN patients.
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
For postoperative morbidity and mortality, surgery alone had the highest probability rate.
HIMALAYA found tremelimumab plus durvalumab to significantly improve overall survival over sorafenib alone.
Dr. Wungki Park gives an overview of the POLAR study for metastatic pancreatic cancer.
Dr. Wungki Park of Memorial Sloan Kettering Cancer Center discusses his trial on the use of ASP3082 for solid tumors.
While biliary tract cancer is one of the fastest-growing types of early-onset cancers, little is known about its biology.
Little is known about the details of genomic differences and clinical implications between patients with GISTs.
The Latest From Heme Today
Most of the research performed up to this point on the influence of clonal dynamics in MDS has focused on high-risk disease.
A majority of patients in the study had complete remission of disease within bone marrow with the combination therapy.
A recent study brings insight regarding the best timing for this CAR-T therapy in patients with prior BCMA-directed therapy.
Dr. Theodore Wun and Dr. Olubusola Oluwole investigated the causes of rising stroke rates among pediatric and adult patients.
Efficacy and safety primary analysis findings are reported from the international, open-label FREEDOM2 trial.
A new study addresses the need for data on treatment outcomes in patients younger than 12 years of age.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.